Preparation of Guidelines for Medication Guidance Regarding Automobile Driving to Patients Based on “Japanese Adverse Drug Event Report” Database by Pharmaceuticals and Medical Devices Agency (PMDA) (Part 1)
10.11256/jjdi.17.59
- VernacularTitle:「PMDA副作用が疑われる症例報告」を用いた自動車運転に関する 服薬指導基準の作成（第一報)
- Author:
Yukiko Okamoto
;
Yasuhisa Hattori
;
Yasuo Nakamura
;
Kaoru Kamimoto
;
Hiroshi Suzumura
- Publication Type:Journal Article
- Keywords:
automobile driving;
traffic accident;
prescription drug;
patient guidance on medication
- From:Japanese Journal of Drug Informatics
2015;17(2):59-68
- CountryJapan
- Language:English
-
Abstract:
Objective: Incidents, such as disturbance of consciousness due to adverse reactions of medications during automobile driving, could cause a serious accident. Although automobile driving is indicated to be “prohibited” in the package inserts of many drugs, no explicit guidelines are available in Japan on specific guidance to patients. Therefore, we attempted to prepare guidelines for medication guidance regarding automobile driving.
Methods: We investigated the number of incidents involving traffic accidents and the disturbance of consciousness cases reported in “Japanese Adverse Drug Event Report” database by “Pharmaceuticals and Medical Devices Agency (PMDA).” We also analyzed descriptions regarding automobile driving found in package inserts and guidelines to determine a risk level for each medication.
Results: Guidelines for medication guidance were prepared based on four-level classification of drugs for which “prohibition” of automobile driving was indicated in their package inserts; these levels are “conform to pertinent guidelines,” “strictly prohibited,” “prohibited,” and “conditionally prohibited.” The contents of the guidance prepared for some drugs were different from their package inserts.
Conclusions: The guidelines prepared in this study can be expected to become a support tool to ensure close attention to cautions regarding automobile driving. Because some contents of the guidance are different from that described in the package inserts, it is desirable to obtain agreement with physicians in hospitals adopting these guidelines. In addition, guidelines based on a broader range of information should be prepared in the future.
